ArticleOncogene2024

Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids.

Hélène Lasolle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.